Promising new molecular targeted therapies in head and neck cancer.
about
Recent Progress in Therapeutic Treatments and Screening Strategies for the Prevention and Treatment of HPV-Associated Head and Neck CancerClinical application of genetics to guide prevention and treatment of oral diseasesResponse of head and neck squamous cell carcinoma cells carrying PIK3CA mutations to selected targeted therapiesToward the use of precision medicine for the treatment of head and neck squamous cell carcinomaNimotuzumab in combination with radiotherapy in high grade glioma patients: a single institution experience.Inhibitors of the PD-1/PD-L1 axis for the treatment of head and neck cancer: current status and future perspectivesSmall-molecule inhibitors of the receptor tyrosine kinases: promising tools for targeted cancer therapiesSquamous cell carcinoma of the scrotum: A look beyond the chimneystacks.Definitive intensity modulated radiotherapy in locally advanced hypopharygeal and laryngeal squamous cell carcinoma: mature treatment results and patterns of locoregional failure.Pneumatosis cystoides intestinalis after cetuximab chemotherapy for squamous cell carcinoma of parotid glandNuclear expression of p65 (RelA) in patients receiving post-operative radiotherapy for locally advanced squamous cell carcinoma of the head and neck.Rapid detection and destruction of squamous cell carcinoma of the head and neck by nano-quadrapeutics.Absent and abundant MET immunoreactivity is associated with poor prognosis of patients with oral and oropharyngeal squamous cell carcinoma.Combining molecular targeted agents with radiation therapy for malignant gliomasNimotuzumab combined with concurrent chemoradiotherapy in locally advanced nasopharyngeal carcinoma: a retrospective analysis.EGF induces epithelial-mesenchymal transition and cancer stem-like cell properties in human oral cancer cells via promoting Warburg effect.HDX-MS takes centre stage at unravelling kinase dynamics.The mutational spectrum of squamous-cell carcinoma of the head and neck: targetable genetic events and clinical impact.Combining antiangiogenic therapy and radiation in nasopharyngeal carcinoma.Soluble guanylate cyclase stimulators increase sensitivity to cisplatin in head and neck squamous cell carcinoma cells.Current Role of Dacomitinib in Head and Neck Cancer.Osteopontin splice variants expression is involved on docetaxel resistance in PC3 prostate cancer cells.Targeting cellular and molecular drivers of head and neck squamous cell carcinoma: current options and emerging perspectives.In vitro study of normoxic epidermal growth factor receptor-induced hypoxia-inducible factor-1-alpha, vascular endothelial growth factor, and BNIP3 expression in head and neck squamous cell carcinoma cell lines: Implications for anti-epidermal growtTreatment Outcomes of 257 Patients with Locoregionally Advanced Nasopharyngeal Carcinoma Treated with Nimotuzumab Plus Intensity-Modulated Radiotherapy with or without Chemotherapy: A Single-Institution Experience.[Gene therapy and stem cells for the inner ear: a review].Genomic insights into head and neck cancer.Targeting HIF1α peri-operatively increased post-surgery survival in a tongue cancer animal model.Precision Therapy of Head and Neck Squamous Cell Carcinoma.Vascular endothelial growth factor-targeted paclitaxel-loaded liposome microbubbles and inhibition of human epidermoid-2 cell proliferation.The Effect of Canertinib on Sensitivity of Cytotoxic Drugs in Tamoxifen-Resistant Breast Cancer Cells In Vitro
P2860
Q26782255-C2F61011-8C3B-40F7-9328-39975BB90852Q26999507-42777481-061B-488B-83F1-D46BF9D73C45Q27853149-10D3F5A4-3833-49E7-AD55-5B16F1F740D8Q28074691-CF252E7F-D860-47BE-A607-56E42AC4D8C9Q33631435-84F03A1B-9968-431C-8044-2A14D7A8DDC5Q33884361-CE41A8C5-7CF7-40EF-BB6E-E37C3B84CB9EQ34158454-C2D1BF20-E0C0-4D40-A66A-96E6FEF7C56FQ34520023-8AEBF21B-5DBB-4269-BEFC-15844A38E548Q35019239-E04FBF34-4324-4F4F-80BE-DD000B79AC56Q35087117-F2445C4A-D816-4DF4-8F06-3BC2A085A418Q35156335-AA95DF84-20B6-4047-B1ED-A6500BBFEDA1Q35560212-3BD1B721-A752-4C56-B57E-DB7B6225F444Q37022410-77AC7477-982F-4B56-A623-44FCAF40C3ADQ37099594-6B26C150-962D-40A1-B0B1-418295AEEB54Q37269328-725EDC18-6767-441D-9CD6-37AB4E443F21Q37706017-0FA8BE9B-2AB8-4935-92CA-32BBF0315CEDQ38180771-C8C3D6B5-E441-453E-AB9E-1671B6C243BAQ38203467-0DD6B143-8034-45DF-B2F4-3BA64F77B9ABQ38489938-AE573C67-DADE-4890-8307-021B98621DFDQ38724210-CD057D37-45B6-402E-9068-DACA7E1E3399Q38806115-430F9E4E-95DB-4CD9-8520-9FF5112CB3CAQ38832738-4EBF36A2-84D2-4CEC-A521-7E6BA476798FQ38838071-5D6AB5B4-A702-4AD7-937C-B946516013C6Q38998235-601BAACF-27FB-4D40-9A10-3A67779562C8Q47301004-A244E9CC-D92F-4EAB-B102-3916B707F542Q50426000-0EE38D0A-364D-45BF-87C2-A7E8B14223D9Q50917827-DEB12800-1135-41E5-9BF1-C60A5AE65604Q51019842-5A8B8E19-8F54-4E59-89FB-46F29620BCFEQ52591781-F095AC2A-7499-44B8-9EBC-45A365E60CE3Q52800481-A3BD506B-DE22-4724-914B-5E6CB650D516Q58697915-BD7B71A8-2FB4-4E06-A6E4-A96AA5DB967A
P2860
Promising new molecular targeted therapies in head and neck cancer.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Promising new molecular targeted therapies in head and neck cancer.
@en
type
label
Promising new molecular targeted therapies in head and neck cancer.
@en
prefLabel
Promising new molecular targeted therapies in head and neck cancer.
@en
P2860
P1433
P1476
Promising new molecular targeted therapies in head and neck cancer.
@en
P2093
Kelly Dorsey
Mark Agulnik
P2860
P2888
P304
P356
10.1007/S40265-013-0025-3
P577
2013-03-01T00:00:00Z
P6179
1042318507